Long‐term follow‐up of contemporary drug‐eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30545
Abstract: The elevated risk of adverse events following percutaneous coronary intervention in diabetic patients persists with newer‐generation DES. The polymer‐free amphilimus‐eluting stent (PF‐AES) possesses characteristics with a potentially enhanced performance in patients with diabetes. Data from… read more here.
Keywords: long term; drug eluting; eluting stent; contemporary drug ... See more keywords
Fifth Contemporary Drug Problems Conference: Rethinking “Change”: New Theories, New Topics, New Questions, New Methods
Sign Up to like & getrecommendations! Published in 2019 at "Contemporary Drug Problems"
DOI: 10.1177/0091450919898067
Abstract: The fifth biennial Contemporary Drug Problems (CDP) conference was held in Prato, Italy, from September 4 to 6, 2019 at the Monash University Prato Centre. The conference was hosted by the Law Faculty at Monash… read more here.
Keywords: research; drug problems; drug; university ... See more keywords
Contemporary Drug Therapy for Renal Cell Carcinoma—Evidence Accumulation and Histological Implications in Treatment Strategy
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10112840
Abstract: Renal cell carcinoma (RCC) is a heterogeneous disease comprising a variety of histological subtypes. Approximately 70–80% of RCC cases are clear cell carcinoma (ccRCC), while the remaining subtypes constitute non-clear cell carcinoma (nccRCC). The medical… read more here.
Keywords: cell carcinoma; cell; renal cell; contemporary drug ... See more keywords